L Annemans

Summary

Affiliation: Ghent University
Country: Belgium

Publications

  1. ncbi request reprint A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain
    L Annemans
    IMS Health, De Crayerstraat 6, 1000 Brussel, Belgium
    Acta Clin Belg 63:170-8. 2008
  2. ncbi request reprint Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation
    L Annemans
    Department of Public Health, Faculty of Medicine, Ghent University, Ghent, Belgium
    Int J Clin Pract 60:1129-37. 2006
  3. ncbi request reprint A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction
    Mark Lamotte
    HEDM IMS, Bruxelles, Belgium
    Herz 31:74-82. 2006
  4. ncbi request reprint Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium
    Lieven Annemans
    Ghent University Hospital, Block A, 2nd Fl, De Pintelaan 185, 9000, Ghent, Belgium
    Pharmacoeconomics 32:479-93. 2014
  5. pmc Valorising and creating access to innovative medicines in the European union
    Lieven Annemans
    Center for Health Economics, Department of Public Health, Ghent University Ghent, Belgium
    Front Pharmacol 2:57. 2011
  6. doi request reprint Current methodological issues in the economic assessment of personalized medicine
    Lieven Annemans
    Department of Public Health, Ghent University, Ghent, Belgium Electronic address
    Value Health 16:S20-6. 2013
  7. ncbi request reprint Maximizing health through the rapidly developing fields of comparative and cost-effectiveness
    Lieven Annemans
    Faculty of Medicine and Health Science, Department of Public Health, De Pintelaan 185, Blok A 2 Verd, Belgium
    J Comp Eff Res 1:479-80. 2012
  8. pmc Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial
    Nick Verhaeghe
    Department of Public Health, Ghent University, Ghent, Belgium
    BMC Public Health 13:657. 2013
  9. pmc Health promotion intervention in mental health care: design and baseline findings of a cluster preference randomized controlled trial
    Nick Verhaeghe
    Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, B 9000, Ghent, Belgium
    BMC Public Health 12:431. 2012
  10. ncbi request reprint The impact of treatment with risperidone long-acting injection on the Belgian healthcare system: results from a budget impact model
    L Annemans
    Ghent University and Brussels University VUB, Belgium
    Acta Clin Belg 67:108-19. 2012

Detail Information

Publications93

  1. ncbi request reprint A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain
    L Annemans
    IMS Health, De Crayerstraat 6, 1000 Brussel, Belgium
    Acta Clin Belg 63:170-8. 2008
    ..To assess the cost per QALY (quality-adjusted life years) of pregabalin in the management of peripheral neuropathic pain...
  2. ncbi request reprint Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation
    L Annemans
    Department of Public Health, Faculty of Medicine, Ghent University, Ghent, Belgium
    Int J Clin Pract 60:1129-37. 2006
    ..In conclusion, low-dose aspirin treatment becomes cost-saving at a very low 10-year risk of fatal CVD. The cost of gastrointestinal bleeding defines the level at which low-dose aspirin becomes cost-saving...
  3. ncbi request reprint A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction
    Mark Lamotte
    HEDM IMS, Bruxelles, Belgium
    Herz 31:74-82. 2006
    ..Adding highly concentrated n-3 PUFAs to standard treatment in the secondary prevention after MI appears to be cost-effective in the 5 countries studied...
  4. ncbi request reprint Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium
    Lieven Annemans
    Ghent University Hospital, Block A, 2nd Fl, De Pintelaan 185, 9000, Ghent, Belgium
    Pharmacoeconomics 32:479-93. 2014
    ..The objective of this study was to assess the cost effectiveness of commonly used antidepressants as first-line treatment of major depressive disorder (MDD) in Belgium...
  5. pmc Valorising and creating access to innovative medicines in the European union
    Lieven Annemans
    Center for Health Economics, Department of Public Health, Ghent University Ghent, Belgium
    Front Pharmacol 2:57. 2011
    ..This could be the task of the European Medicines Agency, HTA bodies, and competent authorities together...
  6. doi request reprint Current methodological issues in the economic assessment of personalized medicine
    Lieven Annemans
    Department of Public Health, Ghent University, Ghent, Belgium Electronic address
    Value Health 16:S20-6. 2013
    ..It is possible that the test will lead to not only fewer QALYs but also fewer costs, which can be defined as "decremental" cost per QALYs. Different decision criteria are needed to interpret such results. ..
  7. ncbi request reprint Maximizing health through the rapidly developing fields of comparative and cost-effectiveness
    Lieven Annemans
    Faculty of Medicine and Health Science, Department of Public Health, De Pintelaan 185, Blok A 2 Verd, Belgium
    J Comp Eff Res 1:479-80. 2012
    ....
  8. pmc Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial
    Nick Verhaeghe
    Department of Public Health, Ghent University, Ghent, Belgium
    BMC Public Health 13:657. 2013
    ..The aim of the study was to examine the effectiveness of a 10-week health promotion intervention, followed by a 6-month follow-up period in individuals with mental disorders living in sheltered housing in the Flanders region (Belgium)...
  9. pmc Health promotion intervention in mental health care: design and baseline findings of a cluster preference randomized controlled trial
    Nick Verhaeghe
    Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, B 9000, Ghent, Belgium
    BMC Public Health 12:431. 2012
    ..In this paper, the design of the study and baseline findings are described...
  10. ncbi request reprint The impact of treatment with risperidone long-acting injection on the Belgian healthcare system: results from a budget impact model
    L Annemans
    Ghent University and Brussels University VUB, Belgium
    Acta Clin Belg 67:108-19. 2012
    ..This report indicates that improvements in adherence and long-term outcomes previously demonstrated for RLAI treatment in Belgium may result in substantial cost benefits to the country's healthcare system...
  11. pmc Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review
    Nick Verhaeghe
    Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185 B 9000 Ghent, Belgium
    Int J Behav Nutr Phys Act 8:28. 2011
    ..Special attention was given if any of the included studies in the review also examined the cost-effectiveness of these health promotion interventions...
  12. pmc Deriving reference values and utilities for the QoL-AGHDA in adult GHD
    J J V Busschbach
    Medical Psychology and Psychotherapy, Erasmus MC, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    Eur J Health Econ 12:243-52. 2011
    ..Ideally, for use in health economics, QoL should be expressed in utilities. The aim of this study was to obtain reference values and utilities for QoL of GHD in adults in Belgium and the Netherlands...
  13. pmc The equity dimension in evaluations of the quality and outcomes framework: a systematic review
    Pauline Boeckxstaens
    Department of Family Medicine, Ghent University, Belgium
    BMC Health Serv Res 11:209. 2011
    ..In this evaluation, a theory-based framework conceptualising equity in terms of equal access, equal treatment and equal treatment outcomes for people in equal need is used to guide the work...
  14. pmc The ties that bind: an integrative framework of physician-hospital alignment
    Jeroen Trybou
    Department of Public Health, Ghent University, Belgium
    BMC Health Serv Res 11:36. 2011
    ..The second approach, noneconomic integration, represents a sociological perspective emphasizing the cooperative nature of their relationship...
  15. pmc Systematic review: Effects, design choices, and context of pay-for-performance in health care
    Pieter Van Herck
    Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium
    BMC Health Serv Res 10:247. 2010
    ..Effect domains include clinical effectiveness, access and equity, coordination and continuity, patient-centeredness, and cost-effectiveness...
  16. ncbi request reprint Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision making
    Lieven Annemans
    Department of Public Health, Ghent University, Ghent, Belgium
    Pharmacoeconomics 26:409-23. 2008
    ..A list of key features (related to time horizon, clinical data input, patient subtypes, budget impact and model calibration) that an ideal model should have in order to better assist decision makers in this field is proposed...
  17. doi request reprint Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain
    Lieven Annemans
    Ghent University, Ghent, and Brussels University, VUB, Brussels, Belgium
    Clin Drug Investig 31:73-86. 2011
    ..For this reason, the adverse-event profile of opioid-based analgesics should be improved to achieve more efficient long-term pain control...
  18. doi request reprint Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis
    Lieven Annemans
    Department of Public Health, Universiteit Gent, Gent, Belgium
    Clin Drug Investig 29:655-65. 2009
    ....
  19. doi request reprint Societal and patient burden of fibromyalgia syndrome
    Lieven Annemans
    Faculty of Medicine, Ghent University Hospital, Ghent, Belgium
    Pharmacoeconomics 27:547-59. 2009
    ..Despite the complex and controversial construct of this syndrome, the results in terms of patient, healthcare payer and societal burden are quite consistent...
  20. ncbi request reprint Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases
    Lieven Annemans
    Ghent University, Ghent, Belgium
    Eur J Cardiovasc Prev Rehabil 14:815-24. 2007
    ..Given the scarce resources that can be spent on health and health care, the objective of this study was to evaluate the long-term health and economic outcomes of controlled and maintained physical exercise in a fitness setting...
  21. ncbi request reprint Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan--a Belgian analysis
    L Annemans
    Ghent University, Belgium
    Acta Clin Belg 62:419-25. 2007
    ..In conclusion, cetuximab plus irinotecan for patients with metastatic CRC, after failure on irinotecan-containing chemotherapy, is rather cost-effective compared with current care in both scenarios tested...
  22. ncbi request reprint Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation
    L Annemans
    Ghent University, Ghent, Belgium
    Transplant Proc 39:3306-12. 2007
    ..The cost-effectiveness of everolimus and MMF versus azathioprine was assessed to 6 months posttransplantation...
  23. ncbi request reprint Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients
    Lieven Annemans
    HEDM, Brussels, Belgium
    Int J Colorectal Dis 23:77-83. 2008
    ..The objective of our study was to analyze the health economic impact of ferucarbotran-enhanced magnetic resonance imaging (MRI) in the diagnosis of hepatic colorectal cancer metastases based on observed changes in medical management...
  24. pmc Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
    L Annemans
    Ghent University, Faculty of Medicine, Department of Public Health, Ghent, Belgium
    Ann Rheum Dis 67:960-6. 2008
    ..To investigate and compare the prevalence, comorbidities and management of gout in practice in the UK and Germany...
  25. ncbi request reprint Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium
    Lieven Annemans
    Ghent University, De Pintelaan 185, 9000, Gent, Belgium
    Support Care Cancer 16:905-15. 2008
    ..We assessed the cost effectiveness of aprepitant-based vs standard prevention in these indications in Belgium...
  26. doi request reprint Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma
    Lieven Annemans
    Faculty of Medicine, University of Ghent, De Pintelaan 185, Ghent, Belgium
    Eur J Dermatol 18:539-46. 2008
    ..Costs calculated from this study confirm predicted cost-effectiveness in the original model for MAL-PDT in the management of AK and BCC...
  27. ncbi request reprint [Is long-term use of clopidogrel cost-effective in high-risk atherothrombotic patients?]
    L Annemans
    Département d Economie de la Santé, Universiteit Gent
    Rev Med Brux 30:11-22. 2009
    ..Sensitivity analyses varying life expectancy, efficacy of clopidogrel, costs of events and cost of adverse events and discount rates demonstrated the robustness of the results...
  28. ncbi request reprint A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis C
    S Gerkens
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Brussels, Belgium
    J Viral Hepat 14:523-36. 2007
    ....
  29. doi request reprint Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial
    E Mehuys
    Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Belgium
    J Clin Pharm Ther 36:602-13. 2011
    ..It is also not known how sustainable any observed effects on glycaemic control are, over time. This study was initiated to address both these issues...
  30. ncbi request reprint Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma
    K Caekelbergh
    HEDM Health Economics and Disease Management, Brussels, Belgium
    Br J Dermatol 155:784-90. 2006
    ..Poor cosmesis resulting from surgical procedures and skin irritation induced by topical agents remain significant problems...
  31. ncbi request reprint Estimating resource use and cost of prophylactic management of neutropenia with filgrastim
    L Annemans
    HEDM, Meise, Belgium
    J Nurs Manag 13:265-74. 2005
    ..77 Euros for a patient without febrile neutropenia, excluding drug costs. With the activity-based costing method it is possible to accurately demonstrate cost savings in the management of neutropenia using the newer drug therapies...
  32. ncbi request reprint Effectiveness of pharmacist intervention for asthma control improvement
    E Mehuys
    Pharmaceutical Care Unit Ghent, Faculty of Pharmaceutical Sciences, Ghent University Hospital, Ghent, Belgium
    Eur Respir J 31:790-9. 2008
    ..In conclusion, pragmatic community pharmacy-based programmes can significantly improve therapeutic outcomes in adult asthma patients...
  33. doi request reprint Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian population
    L Annemans
    Department of Public Health, Ghent University, Ghent, Belgium
    Clin Drug Investig 30:133-42. 2010
    ..This study aimed to estimate the cost effectiveness in the Belgian setting of atorvastatin 10 mg compared with no treatment for the primary prevention of CV events in type 2 diabetes patients without a history of CV disease...
  34. ncbi request reprint Costs associated with readmissions in Belgian acute-care hospitals
    J Trybou
    Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
    Acta Clin Belg 68:263-7. 2013
    ..The goal of this study was to estimate the cost of hospital readmissions at a national level, describe differences in readmission rates between hospitals and to calculate the potential monetary savings of reducing excess readmissions...
  35. doi request reprint Health economic consequences related to the diagnosis of fibromyalgia syndrome
    L Annemans
    IMS Health, Brussels, Ghent University, Ghent, Belgium
    Arthritis Rheum 58:895-902. 2008
    ..To evaluate the use and costs of medical resources before and after a diagnosis of fibromyalgia syndrome (FMS) in a large primary care population in the UK...
  36. ncbi request reprint Assessment of the economic value of the INTERCEPT blood system in Belgium
    K Moeremans
    HEDM, Health Economics and Disease Management, Brussels, Belgium
    Transfus Med 16:17-30. 2006
    ..3 million Euro per lifeyear), IBSP can be considered cost-effective, taking into account the potential risk of emerging pathogens...
  37. ncbi request reprint Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trial
    K Moeremans
    Health Economics and Disease Management, Brussels, Belgium and Public Health Department, Ghent University, Ghent, Belgium
    Int J Gynecol Cancer 16:576-8. 2006
    ..In conclusion, provided that a sufficient time horizon is taken and that long-term model predictions are confirmed from further follow-up from the ATAC study, anastrozole is a highly cost-effective adjuvant therapy compared to tamoxifen...
  38. ncbi request reprint Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings
    J Trybou
    Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
    Acta Clin Belg 68:199-205. 2013
    ..The objectives of this study were to examine the prevalence and the excess costs associated with HAIs...
  39. doi request reprint Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study
    S G Oeyen
    Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium
    Intensive Care Med 39:889-98. 2013
    ....
  40. ncbi request reprint Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium
    L Annemans
    Department of Public Health, Ghent University, Ghent, Belgium
    Acta Clin Belg 59:346-57. 2004
    ....
  41. ncbi request reprint A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patients
    L Annemans
    HEDM, Meise, Belgium
    Acta Gastroenterol Belg 67:1-8. 2004
    ..The objectives of this study were to estimate the long-term clinical consequences of such treatment as well as the resulting cost-effectiveness...
  42. ncbi request reprint Medication use and disease management of type 2 diabetes in Belgium
    Els Mehuys
    Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, Gent 9000, Belgium
    Pharm World Sci 30:51-6. 2008
    ..Diabetes Care 2006;29:S4-42) to propose these services as a pharmacist intervention...
  43. doi request reprint Health economic evaluation of treating anemia in cancer patients receiving chemotherapy: a study in Belgian hospitals
    Erik Spaepen
    IMS Health, Brussels, Belgium
    Oncologist 13:596-607. 2008
    ..This retrospective database study compared the three currently available ESAs, epoetin alfa (EPO-A), epoetin beta (EPO-B), and darbepoetin alfa (DARB), regarding costs and outcomes...
  44. doi request reprint Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection
    Dominique M Vandijck
    Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, Ghent, Belgium
    Int J Antimicrob Agents 31:161-5. 2008
    ..The antibiotic cost associated with ICU-acquired, laboratory-confirmed BSI is significant and should be reduced by implementing infection control measures and preventive strategies...
  45. ncbi request reprint Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections
    Stijn I Blot
    Intensive Care Department, Ghent University Hospital, Ghent, Belgium
    Clin Infect Dis 41:1591-8. 2005
    ..We evaluate clinical and economic outcomes associated with nosocomial central venous catheter-related bloodstream infection (CR-BSI) in intensive care unit (ICU) patients...
  46. doi request reprint Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium
    Lieven Annemans
    Department of Public Health, Ghent University, Ghent, Belgium
    Pharmacoeconomics 27:231-45. 2009
    ....
  47. ncbi request reprint A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease
    Mark Lamotte
    Health Economics and Disease Management, Brussels, Belgium
    Pharmacoeconomics 24:155-69. 2006
    ..The primary objective of this study was to assess the economic consequences of the use of low-dose aspirin in the primary prevention of CVD in four European countries (UK, Germany, Spain and Italy)...
  48. doi request reprint Quality of life after intensive care: a systematic review of the literature
    Sandra G Oeyen
    Department of Intensive Care Medicine, Ghent University Hospital, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
    Crit Care Med 38:2386-400. 2010
    ....
  49. doi request reprint Psychological well-being and socio-economic hardship among AIDS orphans and other vulnerable children in Guinea
    Wim Delva
    International Centre for Reproductive Health, Ghent University, Ghent, Belgium
    AIDS Care 21:1490-8. 2009
    ..This situation calls for sustainable and holistic approaches to ensure the psychological and socio-economic stability of AIDS orphans and other vulnerable children...
  50. ncbi request reprint Long-term medical costs of postmenopausal breast cancer therapy
    V Cocquyt
    Department of Medical Oncology, University Hospital, Ghent, Belgium
    Ann Oncol 14:1057-63. 2003
    ..From a health economic point of view, one is interested in the costs saved by disease prevention...
  51. ncbi request reprint Longitudinal economic consequences of colorectal cancer in a university hospital setting
    M van Gelder
    Universitair Ziekenhuis Gent, Gent, Belgium
    Acta Clin Belg 68:97-100. 2013
    ..There is a need for so called incidence-based cost-analyses, in order to better understand the potential impact of new types of prevention and treatment...
  52. doi request reprint A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results
    J Lambert
    Department of Dermatology, Ghent University Hospital, Belgium
    Arch Dermatol Res 303:57-63. 2011
    ..These positive initial results are stimulating to set up a prospective controlled randomised trial investigating the impact on quality of life, the clinical efficacy and the cost-effectiveness of this educational intervention programme...
  53. doi request reprint Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium
    L Annemans
    Ghent University, Ghent, Belgium
    J Med Econ 13:537-51. 2010
    ..To determine the cost-effectiveness of vaccination against herpes zoster (HZ) and post-herpetic neuralgia (PHN) in individuals aged 60 years and older in Belgium...
  54. ncbi request reprint Injury rate and socioeconomic costs resulting from sports injuries in Flanders: data derived from sports insurance statistics 2003
    E Cumps
    Department of Human Physiology and Sports Medicine, Vrije Universiteit Brussel, Pleinlaan 2 B 1050, Brussels, Belgium
    Br J Sports Med 42:767-72. 2008
    ..This study determines the injury rate (%) and the associated direct medical and indirect costs of sports injuries in Flanders...
  55. ncbi request reprint Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea
    K Moeremans
    HEDM, Health Economics and Disease Management, Brussels, Belgium
    Int J Hematol 82:251-8. 2005
    ..Compared with current treatment with CAB, IVitra therapy was shown to be a cost-effective and cost-saving empirical treatment for PSFI in neutropenic cancer patients and BMT patients...
  56. ncbi request reprint Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients
    L Annemans
    Vrije Universiteit Brussel, Brussels, Belgium
    Eur Addict Res 6:71-8. 2000
    ..A global anticipated net saving of 70 million BEF (1.74 million Euro) over 2 years was estimated for the Belgian health insurance...
  57. ncbi request reprint Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results
    Hilde Van Campenhout
    Medical Department Pfizer, Brussels, Belgium
    Clin Drug Investig 28:509-21. 2008
    ....
  58. ncbi request reprint Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study
    E Mehuys
    Pharmaceutical Care Unit Ghent, Faculty of Pharmaceutical Sciences, Ghent University, Department of Respiratory Diseases, Ghent University Hospital, Harelbekestraat 72, 9000 Ghent, Belgium
    Respir Med 100:1407-14. 2006
    ..9% of the patients. In conclusion, the ACT appears to be a useful tool to determine rapidly and accurately the level of asthma control in patients presenting at community pharmacies...
  59. ncbi request reprint An update: health economics of managing multiple myeloma
    K Moeremans
    HEDM, a unit of IMSHealth, Crayerstraat 6, 1000 Brussels, Belgium
    Eur J Cancer 42:1684-91. 2006
    ..There is also a clear need for peer reviewed economic evaluations of novel therapies such as thalidomide and Bortezomib in the treatment of multiple myeloma at different stages of the disease...
  60. ncbi request reprint A health economic evaluation of concomitant surgical ablation for atrial fibrillation
    Mark Lamotte
    IMS Health Economics and Outcomes Research, Brussels, Belgium
    Eur J Cardiothorac Surg 32:702-10. 2007
    ..g. CABG, valve repair) in comparison with non-interventional (drug) treatment...
  61. ncbi request reprint Cost effectiveness of long-acting risperidone: what can pharmacoeconomic models teach us?
    Lieven Annemans
    Department of Public Health, Ghent University, and HEDM, IMS Health, Brussels, Belgium
    Pharmacoeconomics 23:1-2. 2005
  62. doi request reprint Perceptions of mental health nurses and patients about health promotion in mental health care: a literature review
    N Verhaeghe
    Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
    J Psychiatr Ment Health Nurs 18:487-92. 2011
    ..Despite the awareness of the importance of health promotion in mental health care, it appears that visions and attitudes towards the potential of health promotion are in need of change...
  63. ncbi request reprint An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy
    Lieven Annemans
    Ghent University and IMS Health, Bruxelles, Belgium, and IMS Health, Bruxelles, Belgium
    Value Health 11:354-64. 2008
    ..This treatment has proven to be cost-effective in Western countries. This study assessed the cost-effectiveness of early irbesartan treatment in Asian settings...
  64. doi request reprint Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium
    Lieven Annemans
    Ghent University, Ghent, Belgium
    J Med Econ 11:135-50. 2008
    ..Human papillomavirus (HPV) infections can lead to cervical intraepithelial neoplasia (CIN) lesions, cervical cancer (CC) and genital warts (GWs). This study intended to assess the annual cost of CC, CIN and GW management in Belgium...
  65. ncbi request reprint The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis
    Lieven Annemans
    Department of Public Health, Ghent University, Ghent, Belgium
    BJU Int 96:566-71. 2005
    ..To calculate the economic consequences of using alfuzosin 10 mg once daily for managing acute urinary retention (AUR) related to benign prostatic hyperplasia (BPH)...
  66. ncbi request reprint A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction
    Mark Lamotte
    Health Economics and Outcomes Research, Unit of IMS Health, Brussels, Belgium
    Pharmacoeconomics 24:783-95. 2006
    ..This study assessed the cost effectiveness of adding n-3 PUFAs to the current secondary prevention treatment versus standard prevention alone after acute MI in five countries: Australia, Belgium, Canada, Germany and Poland...
  67. ncbi request reprint Critical appraisal of scientific posters comparing anemia treatments for cancer patients: applying ISPOR Task Force guidelines on methodological quality of retrospective studies
    Nadia Demarteau
    IMS Health, Brussels, Belgium
    Crit Rev Oncol Hematol 63:91-9. 2007
    ..The ISPOR guidelines for the evaluation of retrospective analyses are a useful tool for assessing the quality of scientific posters...
  68. ncbi request reprint Thinking ahead--the rising tide of AIDS orphans
    Wim Delva
    Department of Family Medicine and Primary Health Care, Ghent University, Ghent, Belgium
    S Afr Med J 95:656-8. 2005
  69. ncbi request reprint [Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease]
    Mark Lamotte
    Health Economics and Disease Management Unit IMS Health Bruselas Bélgica
    Rev Esp Cardiol 59:807-15. 2006
    ..This study investigated the health economic implications of using low-dose aspirin in the primary prevention of cardiovascular disease in Spain...
  70. ncbi request reprint Economic burden of pertussis and the impact of immunization
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Pediatr Infect Dis J 24:S48-54. 2005
    ..Despite the existing gaps in data, further research using the most current data should facilitate decisions on new vaccination strategies by describing conditions for favorable results and quantifying the margin of uncertainty...
  71. ncbi request reprint A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
    Koen Demyttenaere
    Department of Psychiatry, University Hospital Gasthuisberg, Leuven, Belgium
    Clin Ther 27:111-24. 2005
    ..Economic evaluations aim to combine costs and patient outcomes in one analysis...
  72. ncbi request reprint The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy
    Roger A Rodby
    Rush Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
    Clin Ther 25:2102-19. 2003
    ..End-stage renal disease (ESRD)-related health care costs are substantial. Improving clinical outcomes in patients at risk of progression to ESRD could lead to considerable health care savings...
  73. ncbi request reprint An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings
    Andrew J Palmer
    Center for Outcomes Research, St Johanns Ring 139, CH 4056 Basel, Switzerland
    Nephrol Dial Transplant 18:2059-66. 2003
    ..A simulation model was developed to project long-term cost consequences of the IDNT in Belgium and France...
  74. ncbi request reprint What reimbursement for coronary revascularization with drug-eluting stents?
    Rosanna Tarricone
    CeRGAS SDA Bocconi University, Milan, Italy
    Eur J Health Econ 5:309-16. 2004
    ..SES is thus a cost-saving strategy in the perspective of the SSN that could therefore support the introduction of the new technology by reimbursing about 80% of its current incremental acquisition cost...
  75. ncbi request reprint Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases
    Jasper M Bos
    Groningen University Institute for Drug Exploration, University of Groningen, Groningen, The Netherlands
    Pharmacoeconomics 22:1171-9. 2004
    ..A numerical example illustrates our approach. We discuss the associated potential implications for public health policy and discuss how the effects of the intervention can be additionally corrected for societal preferences...
  76. ncbi request reprint A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients
    Mark Lamotte
    Health Economics and Disease Management, Brusselsteenweg 91, B 1860 Meise, Belgium
    Diabetes Care 25:303-8. 2002
    ..The objectives of this study were to estimate the long-term clinical consequences of this weight loss and the resulting cost-effectiveness of treating obese type 2 diabetic patients with orlistat...
  77. ncbi request reprint Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patien
    Andrew J Palmer
    CORE Center for Outcomes Research, Buendtenmattstrasse 40, 4102 Binningen Basel, Switzerland
    Diabetes Care 27:1897-903. 2004
    ..The aim of this study was to determine the most cost-effective time point for initiation of irbesartan treatment in hypertensive patients with type 2 diabetes and renal disease...
  78. ncbi request reprint A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels
    Sophie Gerkens
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Bruxelles, Belgium
    Acta Gastroenterol Belg 70:177-87. 2007
    ..The objective of this study was to estimate the cost-effectiveness of their treatment in comparison with no treatment...
  79. ncbi request reprint Discounting health effects in pharmacoeconomic evaluations: current controversies
    J M Bos
    Groningen, University Institute for Drug Exploration, Department of Social Pharmacy, Pharmacoepidemiology, Groningen, The Netherlands
    Pharmacoeconomics 23:639-49. 2005
    ..Instead, results should be presented in a non-aggregated manner that enables policy makers to value health gains according to timing and to which subpopulation they are accrued in...
  80. ncbi request reprint A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension
    Andrew J Palmer
    CORE Center for Outcomes Research, Allschwil Basel, Switzerland
    Curr Med Res Opin 22:2095-100. 2006
    ..We performed a cost-consequence analysis in a French setting of the renoprotective benefit of irbesartan in hypertensive type 2 diabetes patients over a 25-year period...
  81. ncbi request reprint European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment
    Lazzaro Repetto
    Istituto Nazionale di Riposo e Cura per Anziani, Unita Operativa di Oncologia, Via Cassia 1167, Rome 00189, Italy
    Cancer Treat Rev 32:S5-9. 2006
    ..Treatment of anaemia with ESAs is cost-effective and is associated with long-term gains in quality-adjusted life years...
  82. ncbi request reprint A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan
    Kiichiro Tsutani
    The Department of Pharmacoeconomics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
    Intern Med 46:157-62. 2007
    ..This study assessed the health economic consequences of the use of low-dose aspirin in the primary prevention of CVD in Japan...
  83. ncbi request reprint Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis
    Patrick Haentjens
    Department of Orthopaedics and Traumatology, Academisch Ziekenhuis, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    Arch Orthop Trauma Surg 124:507-17. 2004
    ..Whether implementing routine prolonged prophylaxis is cost-effective remains uncertain...
  84. doi request reprint [Cost-effectiveness of darbepoetin alpha in an every-3-weeks schedule]
    Isabelle Borget
    Service d études et de recherche en économie de la santé, Institut Gustave Roussy, Villejuif
    Bull Cancer 95:465-73. 2008
    ..The Q3W schedule is cost saving compare to the QW schedule. It also reduces the burden of the frequent visits for the patients...
  85. ncbi request reprint Health economic evaluation of liver MRI in colorectal cancer patients
    Thomas Helmberger
    Institute of Clinical Radiology, University of Munich, Marchioninistrasse 15, 81377 Munchen, Germany
    Eur Radiol 14:C13. 2004
  86. ncbi request reprint Modeling costs and cost-effectiveness of different CMV management strategies in liver transplant recipients as a support for current and future decision making
    Lieven Annemans
    Health Economics and Disease Management Meise, Belgium
    Value Health 5:347-58. 2002
    ..To develop a generic decision-analytic model to predict health and economic outcomes of different management options for cytomegalovirus (CMV) infection and disease in liver transplant patients...
  87. ncbi request reprint Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium
    Lieven Annemans
    UZ GENT Centrale Apotheek, De Pintelaan 185, 9000 Gent
    Pharm World Sci 24:5-7. 2002
    ..Standard Report Format can support the quality, transparency and exhaustiveness of the data submitted. A multidisciplinary task force developed a Standard Report Format for pharmaco-economic evaluations in Belgium...
  88. ncbi request reprint Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancer
    Karen Moeremans
    Health Economics and Disease Management, Meise, Belgium
    Value Health 7:472-81. 2004
    ..To assess the cost-effectiveness of bicalutamide (Casodex) as adjuvant treatment in early prostate cancer (EPC)...
  89. ncbi request reprint Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis
    Josephine A Mauskopf
    RTI Health Solutions, Research Triangle Park, NC, USA
    Value Health 10:336-47. 2007
    ..The objective of this report is to present guidance on methodologies for those undertaking such analyses or for those reviewing the results of such analyses...
  90. ncbi request reprint Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The Netherlands
    Adrianne Faber
    Groningen University Institute for Drug Exploration, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen, The Netherlands
    CNS Drugs 22:157-70. 2008
    ..Stimulants are the drugs of first choice in the treatment of ADHD. It has been suggested that full costs associated with the treatment of ADHD may be reduced by once-daily administration regimens of stimulants...
  91. ncbi request reprint How to improve screening in first-degree relatives of patients with premature coronary heart disease
    Lieve Debruyne
    Department of Public Health, Ghent University, University Hospital, Ghent, Belgium
    Eur J Cardiovasc Prev Rehabil 13:711-7. 2006
    ..This demonstration project examined how to improve screening of close relatives of patients with premature CHD in daily practice...
  92. ncbi request reprint Economic evaluations in healthcare: comments on a recent article
    Lieven Annemans
    Reprod Biomed Online 11:786. 2005
  93. ncbi request reprint Education in pharmacoeconomics: an international multidisciplinary view
    Karen L Rascati
    College of Pharmacy, The University of Texas, Austin, Texas 78712, USA
    Pharmacoeconomics 22:139-47. 2004
    ..This method can improve the standardisation of the educational process; however, there is still much work to be done in order to achieve real consensus on 'learning outcomes' in pharmacoeconomics...